Cynata Therapeutics Competitors and Similar CompaniesClear all

Cynata Therapeutics's competitors and similar companies include VALANX Biotech, Longeveron, Solid State Pharma and Integra.
Cynata Therapeutics
Cynata Therapeutics
Cynata Therapeutics is a stem cell and regenerative medicine company focused on the development of therapies based on Cymerus, a proprietary therapeutic stem cell platform technology.
VALANX Biotech
VALANX Biotech
VALANX Biotech is a company that provides technology for site-specific protein conjugation with a focus on the therapeutics, diagnostics, and biocatalysis sectors.
Longeveron
Longeveron
Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases.
Solid State Pharma
Solid State Pharma
Solid State Pharma is a solid-state science and crystallization engineering company.
Integra
Integra
Integra is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions.
Founding Date
Founding Date
2011
Founding Date
2017
Founding Date
2014
Founding Date
2014
Founding Date
1989
Type
Type
Public
Type
Private
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Carlton, AU HQ
Cremorne, AU
Hawthorn, AU
Locations
HQ
Locations
Miami, US HQ
Locations
Halifax, CA HQ
Locations
Jerusalem, IL HQ
Employees
Employees
N/A
Employees
157% increase
Employees
259% increase
Employees
32
Employees
7
Valuation ($)
Valuation ($)
33.8 m
Valuation ($)
N/A
Valuation ($)
31.4 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$1.2m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$396k (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$1.9m (FY, 2025)
Gross profit
N/A
Gross profit
$803k (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($9.4m) (FY, 2025)
Net income
N/A
Net income
($22.7m) (FY, 2025)
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 168.1k (almost 9 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 25m (over 8 years ago)
Total funding raised
Total funding raised
$ 14.1m
Total funding raised
$ 268.1k
Total funding raised
$ 9m
Total funding raised
N/A
Total funding raised
$ 28m
For sources of this data, please see the company profile

View Company Profiles

VALANX Biotech
HQ
Employees
15↑ 7% increase

VALANX Biotech is a company that provides technology for site-specific protein conjugation with a focus on the therapeutics, diagnostics, and biocatalysis sectors.

View company
Longeveron
HQ
Miami, US
Employees
25↑ 9% increase

Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases.

View company
Solid State Pharma
HQ
Halifax, CA
Employees
32

Solid State Pharma is a solid-state science and crystallization engineering company.

View company
Integra
HQ
Jerusalem, IL
Employees
7

Integra is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions.

View company